期刊文献+

光谱法研究金属离子与肿瘤抑制蛋白p53的DNA结合结构域的相互作用 被引量:5

Spectrometric Studies for Interaction Between Metal Ions and DNA Binding Domain of Tumor Suppressor Protein p53
暂未订购
导出
摘要 利用荧光滴定法研究了9种金属离子与序列特异性的DNA结合结构域(p53DBD)的结合反应,其结合能力依次为Fe3+>Zn2+>Cu2+>Ca2+>Mg2+>Ba2+>Mn2+>Ni2+>Co2+。圆二色谱研究结果表明,Ba2+,Ca2+,Co2+,Mn2+及Ni2+并未引起蛋白二级结构变化;Zn2+,Mg2+及Fe3+诱导蛋白结构细微调整;而Cu2+结合导致蛋白螺旋结构大量丢失。ANS结合研究结果表明,Mg2+与Zn2+相似,诱导p53DBD蛋白表面疏水性增强,而Fe3+引起p53DBD蛋白表面疏水性降低。因此,Mg2+和Fe3+可能是影响或调节p53活性的潜在因子之一。 Site-specific recognition and DNA-binding activity of tumor suppressor protein ( p53 ) are crucial for its tumor suppressor function. Previous reports have shown that metal ions could affect specific recognition and DNA-binding activity of p53 DNA binding domain (DBD). In this study, the binding reaction between p53DBD and nine kinds of metal ions was investigated by fluorescence titration method; the binding affinity of metal ions to p53DBD is Fe^3+ 〉Zn^2+ 〉 Cu^2+ 〉 Ca^2+ 〉 Mg^2+ 〉 Ba^2+ 〉 Mn^2+ 〉 Ni^2+ 〉 Co^2+. The analysis of the far-UV CD data clearly suggested that the binding of Ba^2+ , Ca^2+ , Co^2+ , Mn^2+ and Ni^2+ did not induce the changes in protein secondary structure. The binding of Zn^2+ , Mg^2+ and Fe^3+ induced a subtle conformational change, while the binding of Cu^2 + resulted in a lot of loss in its helical content. The analysis of 8-anili- no-l-naphthalenesulfonic acid (ANS) binding data showed that the binding of Mg^2+ enhanced hydrophobic exposure on protein surface like Zn^2+, while Fe^3+ decreased hydrophobic exposure. Therefore, Mg^2+ and Fe^3 + may be one of potential factors to affect or regulate the transactivation of p53.
出处 《分析化学》 SCIE EI CAS CSCD 北大核心 2009年第8期1131-1136,共6页 Chinese Journal of Analytical Chemistry
基金 国家自然科学基金(No.90403140)资助项目
关键词 金属离子 蛋白结构 亲和性 疏水性 荧光光谱 Metal ions, protein structure, affinity, hydrophobic, fluorescence spectrum
  • 相关文献

参考文献18

  • 1Tottey S,Waldron K J,Firbank S J,Reale B,Bessant C,Sato K,Cheek T R,Gray J,Banfield M J,Dennison C,Robinson N J.Nature,2008,455:1138-1142.
  • 2Glusker J P,Katz A K,Bock C W.The Rigaku Journal.1999,16:8-16.
  • 3Ko L J,Prives C.Genes Dev.,1996,10:1054-1072.
  • 4Levine A J.Cell,1997,88:323-331.
  • 5Prives C.Cell,1994,78:543-546.
  • 6Bargonetti J,Manfredi J J,Chen X,Marshak D R,Prives C.Genes Dev,1993,7:2565-2574.
  • 7Hainaut P,Soussi T,Shomer B,Hollstein M,Greenblatt M,Hovig E,Harris C C,Montesano R.Nucl.Acids Res.,1997,25:151-157.
  • 8Pietenpol J A,Tokino T,Thiagalingam S,el-Deiry W S,Kinzler K W,Vogelstein B.Proc.Natl.Acad.Sci.USA,1994,91:1998-2002.
  • 9Cho Y,Gorina S,Jeffrey P D,Pavletich N P.Science,1994,265:346-355.
  • 10Meplan C,Richard M J,Hainaut P.Oncogene,2000,19:5227-5236.

同被引文献43

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部